Trials / Completed
CompletedNCT06141590
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study was open-label, randomized, fed, single-dose, 2-groups, 2 periods, crossover designe to compare the safety and pharmacokinetics of UI068 and co-administration of UIC202205 and UIC202206.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | administration of UI068 | Test |
| DRUG | administration of UIC202205, UIC202206 | Reference |
Timeline
- Start date
- 2023-03-11
- Primary completion
- 2023-08-29
- Completion
- 2023-08-29
- First posted
- 2023-11-21
- Last updated
- 2023-11-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06141590. Inclusion in this directory is not an endorsement.